Medis - Version QFR - Quantitative Flow Ratio Software
Quantitative Flow Ratio (QFR) from Medis Medical Imaging offers a novel, safe1, non-invasive approach to physiology designed to enhance procedural efficiency2, drive economic value* and improve the patient’s procedural experience**. Medis QFR is being distributed by ACIST Medical in North America only.
Product Details
- Supported by extensive clinical evidence and a large number of trials and publications3
- Excellent correlation and accuracy compared to FFR4
- Strong diagnostic performance compared to iFR5
- Performed in more than 12,000 patients and 16,000 vessels3
- Peer-reviewed in more than 85 publications3
How It Works
- A 3D model is reconstructed from two angiography images to calculate QFR.
- You are then presented with physiological and anatomicalinformation on one screen.
Benefits
Improve patient experience** and delivery efficient workflow.
Improved patient experience**
- No adenosine needed
- No invasive pressure wire required
- Shorter procedure time
Safe1, accurate4 & streamlined workflow
- Applicable pre, during, and post PCI
- Supports predictable treatment with Residual QFR
- Reduces physiological assessment time by 29%2
Cost savings*
- No purchase of capital equipment required
- No adenosine or pressure wire used
- Efficient workflow both online and off
References
- Arturo Cesaro, et al; Fractional assessment of coronary stenosis; An overview of available techniques. Is quantitative flow ratio a step to the future? 2018 July 11.
- Westra J, Andersen BK, et al; Diagnostic performance of in-procedure angiography-derived Quantitative Flow Reserve compared to pressure-derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study. J Am Heart Assoc 2018.
- Data on file. 35-100018.
- Choi et al. Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease. International Journal of Cardiology. Sept 2020.
- Emori H, Kubo T, Ket al; Quantitative flow ratio and instantaneous wave-free ratio for the assessment of the functional severity of intermediate coronary artery stenosis. Coronary Artery Disease 2018.
* Reduced side effect profile when compared to FFR with adenosine induced hyperemia
** Cost savings based on the reduced cost of QFR compared to conventional FFR and the respective cost of administration of hyperemic agent (adenosine) and additional invasive proce dural resources
Downloads related to this software
Customer reviews
No reviews were found for Medis - Version QFR - Quantitative Flow Ratio Software. Be the first to review!